Daniel Ness

2.5k total citations
27 papers, 1.5k citations indexed

About

Daniel Ness is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Daniel Ness has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Daniel Ness's work include Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Daniel Ness is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Daniel Ness collaborates with scholars based in United States, Switzerland and Germany. Daniel Ness's co-authors include Larry G. Hansen, Susan L. Schantz, Jamal Moshtaghian, Patrick C. May, Sue G. Griffith, Gene G. Kinney, Michael Grundman, Dale B. Schenk, Susanne Ostrowitzki and Martin Koller and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Daniel Ness

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ness United States 14 579 425 297 280 231 27 1.5k
Wenfeng Yu China 22 360 0.6× 137 0.3× 716 2.4× 281 1.0× 206 0.9× 65 1.4k
Vicki Waetzig Germany 23 200 0.3× 146 0.3× 1.2k 4.1× 536 1.9× 187 0.8× 38 2.1k
Gabriela A. Salvador Argentina 25 381 0.7× 207 0.5× 805 2.7× 290 1.0× 63 0.3× 62 1.7k
Wenlin An China 18 628 1.1× 69 0.2× 1.1k 3.8× 291 1.0× 208 0.9× 32 1.8k
Annette C. Smith United States 21 389 0.7× 272 0.6× 1.1k 3.9× 743 2.7× 126 0.5× 34 1.6k
Sunhong Kim South Korea 21 314 0.5× 426 1.0× 1.2k 4.0× 370 1.3× 93 0.4× 48 2.0k
Rapee Boonplueang United States 9 198 0.3× 324 0.8× 424 1.4× 240 0.9× 45 0.2× 9 1.0k
Kerri J. Kinghorn United Kingdom 17 525 0.9× 167 0.4× 604 2.0× 187 0.7× 153 0.7× 23 1.4k
Fahad Ali India 21 159 0.3× 113 0.3× 728 2.5× 174 0.6× 243 1.1× 41 1.5k
N. C. Inestrosa Chile 15 514 0.9× 69 0.2× 661 2.2× 232 0.8× 228 1.0× 30 1.2k

Countries citing papers authored by Daniel Ness

Since Specialization
Citations

This map shows the geographic impact of Daniel Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ness more than expected).

Fields of papers citing papers by Daniel Ness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ness. The network helps show where Daniel Ness may publish in the future.

Co-authorship network of co-authors of Daniel Ness

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ness. A scholar is included among the top collaborators of Daniel Ness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ness. Daniel Ness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ness, Daniel & Jonathon Olsburgh. (2019). UTI in kidney transplant. World Journal of Urology. 38(1). 81–88. 15 indexed citations
2.
Lipsmeier, Florian, Kirsten I. Taylor, Ronald B. Postuma, et al.. (2019). Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in recently diagnosed Parkinson patients (P4.7-005). Neurology. 92(15_supplement). 1 indexed citations
3.
Jankovic, Joseph, Ira Goodman, Beth Safirstein, et al.. (2018). Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease. JAMA Neurology. 75(10). 1206–1206. 224 indexed citations
4.
Makki, Daoud, et al.. (2018). The Role of Clinical Examination in Predicting Relevant MRI Findings in Acute Knee Injuries: A Retrospective Study. The Journal of Knee Surgery. 32(3). 280–283. 1 indexed citations
5.
Bergeron, Marcelle, C O Willits, Simeon Bowers, et al.. (2013). Pharmacological inhibition of Polo Like Kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei. Toxicology and Applied Pharmacology. 269(1). 1–7. 9 indexed citations
6.
Ness, Daniel, Zhao Ren, Shyra J. Gardai, et al.. (2013). Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis. PLoS ONE. 8(6). e66164–e66164. 65 indexed citations
7.
Winderlich, Mark, Daniel Ness, Stefan Steidl, & Jan Endell. (2012). Evaluation of combination therapies with MOR00208, an Fc-enhanced humanized CD19 antibody, in models of lymphoma.. Journal of Clinical Oncology. 30(15_suppl). 6574–6574. 3 indexed citations
8.
Endell, Jan, Rainer Boxhammer, Cornelia Wurzenberger, Daniel Ness, & Stefan Steidl. (2012). The Activity of MOR202, a Fully Human Anti-CD38 Antibody, Is Complemented by ADCP and Is Synergistically Enhanced by Lenalidomide in Vitro and in Vivo. Blood. 120(21). 4018–4018. 31 indexed citations
9.
Schroeter, Sally, Elizabeth Brigham, Ruth Motter, et al.. (2010). P3‐321: APP‐selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_18). 3 indexed citations
10.
Bercu, Joel P., Wherly P. Hoffman, Cindy Lee, & Daniel Ness. (2008). Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance. Regulatory Toxicology and Pharmacology. 51(3). 270–277. 14 indexed citations
11.
12.
Siemers, Eric, Michael Skinner, Robert A. Dean, et al.. (2005). Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers. Clinical Neuropharmacology. 28(3). 126–132. 171 indexed citations
13.
Ness, Daniel, Leonard N. Boggs, Deena L. Hepburn, et al.. (2004). P2-053 Reduced β-amyloid burden, increased C-99 concentrations and evaluation of neuropathology in the brains of PDAPP mice given LY450139 dihydrate daily by gavage for 5 months. Neurobiology of Aging. 25. S238–S239. 26 indexed citations
14.
Ness, Daniel. (1996). Effects of 3-Iodo-?-tyrosine, a Tyrosine Hydroxylase Inhibitor, on Eye Pigmentation and Biogenic Amines in the Planarian,Dugesia dorotocephala. Fundamental and Applied Toxicology. 30(2). 153–161. 18 indexed citations
15.
16.
Ness, Daniel, et al.. (1995). Spatial Learning Deficits in Adult Rats Exposed to ortho-Substituted PCB Congeners during Gestation and Lactation. Toxicological Sciences. 26(1). 117–126. 4 indexed citations
17.
Ness, Daniel, Susan L. Schantz, & Larry G. Hansen. (1994). PCB congeners in the rat brain: Selective accumulation and lack of regionalization. Journal of Toxicology and Environmental Health. 43(4). 453–468. 30 indexed citations
18.
Haschek, Wanda M., Daniel Ness, W. F. Hall, et al.. (1994). Temporal and dose-response features in swine fed corn screenings contaminated with fumonisin mycotoxins. Mycopathologia. 126(1). 27–40. 57 indexed citations
19.
Ness, Daniel, Susan L. Schantz, Jamal Moshtaghian, & Larry G. Hansen. (1993). Effects of perinatal exposure to specific PCB congeners on thyroid hormone concentrations and thyroid histology in the rat. Toxicology Letters. 68(3). 311–323. 181 indexed citations
20.
Haschek, Wanda M., Daniel Ness, K. Harlin, et al.. (1992). Characterization of fumonisin toxicity in orally and intravenously dosed swine. Mycopathologia. 117(1-2). 83–96. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenfeng Yu Breakdown of academic impact, for papers by Vicki Waetzig Breakdown of academic impact, for papers by Gabriela A. Salvador Breakdown of academic impact, for papers by Wenlin An Breakdown of academic impact, for papers by Annette C. Smith Breakdown of academic impact, for papers by Sunhong Kim Breakdown of academic impact, for papers by Rapee Boonplueang Breakdown of academic impact, for papers by Kerri J. Kinghorn Breakdown of academic impact, for papers by Fahad Ali Breakdown of academic impact, for papers by N. C. Inestrosa
Rankless by CCL
2026